As of 2025-09-13, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (2.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -422.5%.
The range of the Relative Valuation is (1.12) - (4.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.7x - 10.8x | 6.8x |
| Forward P/E multiples | 2.7x - 10.7x | 6.7x |
| Fair Price | (1.12) - (4.45) | (2.79) |
| Upside | -229.5% - -614.0% | -422.5% |
| Date | P/E |